Biotech News
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
investors.exagen.com2026-05-06 15:13 EST
CARLSBAD, Calif. , Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2025, being held October 24-29, 2025 , at